GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (FRA:OFK) » Definitions » Accounts Payable & Accrued Expense

Orion Oyj (FRA:OFK) Accounts Payable & Accrued Expense : €117 Mil (As of Sep. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Orion Oyj Accounts Payable & Accrued Expense?

Orion Oyj's quarterly accounts payable & accrued expense declined from Mar. 2024 (€85 Mil) to Jun. 2024 (€77 Mil) but then increased from Jun. 2024 (€77 Mil) to Sep. 2024 (€117 Mil).

Orion Oyj's annual accounts payable & accrued expense increased from Dec. 2021 (€102 Mil) to Dec. 2022 (€122 Mil) but then declined from Dec. 2022 (€122 Mil) to Dec. 2023 (€121 Mil).

Orion Oyj Accounts Payable & Accrued Expense Historical Data

The historical data trend for Orion Oyj's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Oyj Accounts Payable & Accrued Expense Chart

Orion Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.70 94.10 102.00 121.90 120.90

Orion Oyj Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.10 120.90 85.40 76.90 117.10

Orion Oyj Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Orion Oyj Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (FRA:OFK) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
OSTO:SEB A OSTO:SWED A OSTO:NORION OSTO:TFBANK OSTO:AZA LLY OCSE:NOVO B JNJ ABBV MRK XSWX:ROG LSE:AZN XSWX:NOVN AMGN PFE XPAR:SAN GILD BMY LSE:GSK TSE:4519
Traded in Other Exchanges
ORINY:USA ORINF:USA 1ORNBV:Italy ORNBVh:UK 0M2O:UK 0M2N:UK ORNBV:Finland ORNAV:Finland
Address
Orionintie 1, Espoo, FIN, FI-02200
Website
https://www.orion.fi
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.

Orion Oyj Headlines

No Headlines